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The transcription factor Nur77, an orphan member of 
the nuclear hormone receptor superfamily, is highly 
expressed during T cell receptor-signaled apoptosis, 
suggesting a possible role for Nur77 in negative selec- 
tion. We examined this by generating two sets of 
transgenic mice. In one set of mice, a dominant- 
negative Nur77 mutant is constitutively expressed and 
the other in which wild-type Nur77 protein is constitu- 
tively expressed in developing thymocytes. We report 
that inhibition of endogenous Nur77 by the dominant- 
negative mutant perturbed T cell development and in- 
hibited antigen-induced negative selection in F5 T cell 
receptor transgenic mice. Constitutive expression of 
wild-type Nur77 protein induced apoptosis in devel- 
oping thymocytes, resulting in a decreased number of 
thymocytes and mature T cells. Together, these data 
support a role for Nur77 in the downstream signaling 
events in antigen-induced negative selection. 
Introduction 
Helper and cytotoxic T cells express T cell antigen recep- 
tor (TCR) composed of an a and 8 chain and recognize 
peptides of foreign antigen bound to molecules encoded 
in the major histocompatibility complex (MHC). The ability 
of these cells to discriminate between self-antigens and 
foreign antigens in the context of self-MHC results from 
two selection processes that occur during T cell develop- 
ment. The process of positive selection promotes matura- 
tion of thymocytes expressing TCR recognizing self-MHC, 
whereas negative selection results in apoptosis of self- 
reactive cells (for review, see Nossal, 1994; Robey and 
Fowlkes, 1994; von Boehmer, 1994, and references 
therein). 
Positive and negative selection of thymocytes occurs at 
an intermediate stage in T cell development, after re- 
arrangement of TCR a and 8 chain genes and transition 
of thymocytes from an early TCR-CDCCD8- double- 
negative stage to a stage in development in which thymo- 
cytes express low levels of TCR and both CD4 and CD8 
coreceptor molecules. TCRbCD4+CD8+ double-positive 
thymocytes expressing TCR that recognizes self-MHC 
molecules undergo positive selection mediated by TCR 
and coreceptor molecules. Positively selected thymocytes 
down-regulate expression of CD4 or CD8, up-regulate 
TCR expression, and mature to either TCRh’CD4+CD8- 
class II MHC-restricted helper T cells or TCRhiCD4-CD8+ 
class I MHC-restricted cytotoxic T cells. Double-positive 
thymocytes expressing TCR with too high of an affinity/ 
avidity for self-peptide/MHC undergo negative selection, 
resulting in death by apoptosis (for review, see Nossal, 
1994; Robey and Fowlkes, 1994; von Boehmer, 1994). 
Immature thymocytes at the double-positive stage in de- 
velopment have a lifespan of several days. If they fail to 
express TCR or express TCR that does not recognize self- 
MHC molecules, they fail to receive maturation and sur- 
vival signals associated with positive selection, and die 
by apoptosis. Neglected double-positive thymocytes rep 
resent the vast majority of thymocytes. These cells and 
negatively selected thymocytes are cleared from the thy- 
mus by thymic macrophages when they become apoptotic 
(Savill et al., 1993; Surh and Sprent, 1994; Veis et al., 
1993). 
The nur77 gene was identified in a differential screen 
of T ceil hybridomas for genes expressed during TCR- 
signaled apoptosis, suggesting that it may play a role in 
negative selection (Liu et al., 1994; Woronicz et al., 1994). 
The nur77 (NGFI-B) gene was originally characterized as 
a gene expressed in response to mitogenic signals in NIH 
3T3 cells and in response to both mitogenic and differ- 
entiative signals in the PC12 neuronal cells line (Hazel et 
al., 1988; Milbrandt, 1988; Ryseck et al., 1989). In T cell 
hybridomas, expression of the nur77 gene is rapidly in- 
duced in response to TCR signaling. A high level of Nur77 
protein expression is maintained throughout the apoptotic 
process in these cells (Woronicz et al., 1994). Injection of 
mice with anti-CD3 antibodies induces apoptosis in thymo- 
cytes and a high level of Nur77 expression, demonstrating 
a correlation between nur77 expression and apoptosis of 
thymocytes(Woroniczetal., 1994). Nur77hasbeenshown 
to be required for TCR-signaled apoptosis in Tcell hybrido- 
mas. Stable expression of a dominant-negative Nur77 pro- 
tein or transient expression of antisense Nur77 RNA has 
been shown to inhibit TCR-signaled apoptosis of these 
cells (Liu et al., 1994; Woronicz et al., 1994). 
The Nur77 protein belongs to the steroid receptor super- 
family of liganddependent transcription factors (Hazel et 
al., 1988; Milbrandt, 1988; Ryseck et al., 1989). The do- 
main organization of proteins in this family includes an 
N-terminal transactivation domain, a Zn finger DNA- 
binding domain, and a C-terminal ligand-binding domain. 
The DNA-binding domain of Nur77 contains an additional 
element, termed an A box, that recognizes 5’ A residues 
in the Nur77 DNA binding site (5QIAAAGGTCA-3’) (Wilson 
et al., 1991,1992,1993b). Among members of this family, 
the Nur77 protein is unusual in that it appears to bind its 
target element as a monomer (Wilson et al., 1993a). A 
ligand for Nur77 has yet to be identified, which has led to 
its classification as an orphan steroid receptor (Davis et 
al., 1993; Fahrner et al., 1990; Paulsen et al., 1992; Yoon 
and Lau, 1993). 
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Although Nur77 has been shown to be required for TCR- 
signaled apoptosis in T cell hybridomas, it is not clear 
whether the molecular mechanisms leading to the death of 
T cell hybridomas are similar to the mechanisms initiated 
during the process of negative selection. In addition, the 
function of the Nur77 protein in TCR-signaled apoptosis 
is not understood. Here, we examined a role for the Nur77 
protein in the process of antigen-induced negative selec- 
tion. We report that a dominant-negative Nur77 protein 
inhibits antigen-induced negative selection of thymocytes 
in vivo. The dominant-negative protein does not block posi- 
tive selection of thymocytes but perturbs T cell develop- 
ment, causing an increase in the number of mature 
CD4+CD8- thymocytes. We also report that constitutive 
Nur77 expression induces apoptosis in developing thymo- 
cytes. Together, these results support a role for Nur77 in 
the downstream events in antigen-induced negative se- 
lection. 
Results 
Generation of Nur77 Transgenic Mice 
We examined a role for the orphan steroid receptor Nur77 
in the process of negative selection from two perspectives. 
We reasoned if Nur77 regulated genes involved in the 
downstream events in negative selection, that a dominant- 
negative mutant of the Nur77 protein would inhibit nega- 
tive selection; whereas, constitutive Nur77 expression 
might induce apoptosis in thymocytes. We generated two 
sets of transgenic mice based on this rationale. In one set 
of mice, a dominant-negative Nur77 mutant, containing 
the Zn finger A box DNA-binding domain through the 
C-terminal ligand-binding domain of Nur77, is expressed 
in developing thymocytes. This dominant-negative Nur77 
protein is the same one that has been shown to block 
TCR-signaled apoptosis of T cell hybridomas (Woronicz 
et al., 1994). In a second set of mice, wild-type Nur77 
protein is constitutively expressed in thymocytes. We refer 
to the mice as Nur77-ZnCT and Nur77-FL mice and to 
the protein products of the transgenes in the same man- 
ner. The T cell-specific Ick proximal promoter regulates 
transgene expression in both sets of mice (Figure 1A). 
Expression from this promoter has been shown to be very 
strong in immature thymocytes, down-regulated as thymo- 
cytes mature, and relatively inactive in mature T cells (Al- 
len et al., 1992). 
To verify expression of the dominant-negative protein 
in Nur77-ZnCTtransgenic mice and to compare the levels 
of dominant-negative protein and endogenous Nur77 pro- 
tein, an electrophoretic mobility shift assay was performed 
with a probe containing the Nur77 DNA binding site. 
Nur77-ZnCT protein has previously been shown to bind 
to the Nur77 site with high specificity (Wilson et al., 1991, 
1992; Woronicz et al., 1994). Line 18 and 15 Nur77-ZnCT 
transgenic mice were found to express relatively high lev- 
els of Nur77-ZnCT protein in thymocytes compared with 
the level of endogenous Nur77 protein that is induced by 
stimulating thymocytes with ionomycin and phorbol myris- 
tate acetate (Figure 16). A mobility shift binding assay 
was also used to verify Nur77-ZnCT protein expression 
A 
Nur77-FL Ick momo~cr TAD znZnA CT I - hGH 
Nur77UnCT Ick wmofer~ -, hGH 
6 
non-Tg Tramgenic 
- ‘line15 lids’ 
III 
- + - + - + 
1 2 3 4 5 6 
C 
P3 Tg 
PMAAono: - + - 
Figure 1. Diagrams of the Nur77 Transgenes and Analyses to Detect 
Protein Products of the Transgenes in Thymocytes from Transgenic 
Mice 
(A) Nur77-FL (upper) and Nur77-ZnCT (lower) transgenes. The Ick- 
proximal promoter regulates transgene expression and sequences 
from the human growth hormone gene (hGH) facilitate mRNA pro- 
cessing. Functional domains of the wild-type Nur77 protein include 
an N-terminal transactivation domain (TAD), a Zn finger A box DNA- 
binding domain (Zn Zn A), and a C-terminal ligand-binding domain 
(CT). 
(B)An electrophoretic mobility shift assay using the Nur77 DNAbinding 
site detected Nur77-ZnCT protein binding activity in thymocytes from 
Nur77-ZnCT transgenic mice and endogenous Nur77 protein binding 
activity in thymocytes stimulated for 2 hr with ionomycin and PMA, 
indicated by a plus. Data shown is from line 18 and line 15 mice. 
Complexes containing the dominant-negative protein are distin- 
guished from those containing endogenous Nur77 based on a differ- 
ence in mobility. 
(C) Western blot analysis using 2Cl anti-mouse Nur77 monoclonal 
antibody to detect Nur77 expression in thymocytes from Nur77-FL 
transgenic mice. Nur77 was detected in unstimulated thymocytes from 
transgenic mice but not in unstimulated thymocytes from non- 
transgenic mice, confirming that Nur77 protein in transgenic animals 
is expressed from the transgene. Thymocytes in which expression of 
endogenous Nur77 was induced by stimulation with .5 uM ionomycin 
and 10 nglml PMA sewed as a positive control, and is indicated by 
a plus. 
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in peripheral T ceils. Lower levels of the protein were ob- 
served in peripheral T cells, consistent with the known 
decrease in activity of Ick proximal promoter in mature T 
cells (data not shown). 
Constitutive expression of full-length Nur77 protein in 
thymocytes from Nur77-FL transgenic mice was con- 
firmed by Western blot analysis of whole cell extract using 
2El anti-mouse Nur77 monoclonal antibody (Fahrner et 
al., 1990). Full-length Nur77 protein was detected in whole 
Cell extract from unstimulated transgenic thymocytes but 
not in extract from unstimulated nontransgenic thymo- 
cytes (Figure 1C). Since nur77 is an activation-induced 
gene in T cells, stimulation of thymocytes with ionomycin 
and PMA or with anti-CD3 antibodies is usually required to 
detect Nur77 protein in thymocytes, indicating that Nur77 
protein detected in unstimulated transgenic thymocytes 
is protein expressed from the transgene. The DNA binding 
activity of Nur77 protein in transgenic thymocytes wasveri- 
fied by an electrophoretic mobility shift assay (data not 
shown). We concentrated our analysis on line 5 of these 
mice. A second line shows similar results. 
Expression of a Dominant-Negative Nur77 Protein 
Perturbs T Cell Development 
We first examined Nur77-ZnCT transgenic mice for any 
effect of the dominant-negative protein on T cell develop- 
ment. Lymphocyte counts were determined in these mice 
and T cell development analyzed by flow cytometry based 
on expression of the coreceptor molecules CD4 and CD8 
and on CD3 expression for TCR levels. Nur77-ZnCT 
transgenic mice were found to have a moderate reduction 
in thymocyte number, which correlated with a reduction 
in the absolute number of CD4+CD8+ thymocytes in these 
mice (Figures 2A and 28). These mice were also found 
to have an increase in the absolute number of mature 
CD4+CD8- thymocytes, reflected as an increase in the 
number of cells expressing high levels of CD3. An appar- 
ent increase in the percentage of mature CD4-CD8+ thy- 
mocytes was observed but is not real in terms of a change 
in the absolute number of these cells (Figures 2A and 
26). The phenotypic changes observed in heterozygous 
Nur77-ZnCT transgenic mice were found to be more pro- 
nounced in homozygous transgenic mice, indicating a 
dosage effect of the dominant-negative protein on T cell 
development (Figure 2A). The same phenotypic changes 
were observed in both line 18 and line 15 Nur77-ZnCT 
transgenic mice (Figure 28). Although the dominant- 
negative Nur77 protein perturbed thymocyte develop- 
ment, the number of T cells in the lymph nodes and spleen 
and the ratio of CD4 to CD8 cells in Nur77-ZnCT mice 
were found to be approximately the same as in non- 
transgenic littermate controls (data not shown). 
To examine further T cell development in Nur77-ZnCT 
transgenic mice, expression patterns of the develop- 
mental markers CD89, HSA, and CD5 were analyzed by 
flow cytometry. In normal mice, expression of CD5 in- 
creases and expression of HSA decreases after positive 
selection of thymocytes (Bendelac and Schwartz, 1991; 
Crispe and Bevan, 1987; Godfrey and Zlotnik, 1993; 
Ramsdell et al., 1991; Wilson et al., 1988). CD89 is an 
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Figure 2. Analyses of Nur77-ZnCT Transgenic Mice for Changes in 
T Cell Development 
(A) Flow cytometric analysis of thymocytes from line 15 Nur77-&CT 
transgenic mice. CD4, CD& and CD3 expression on thymocytes from 
a nontransgenic (Wvwt), heterozygous (tglwt), and homozygous (tg/ 
tg) mouse. Data shown is from B-week-old male littermates. 
(6) Absolute number of thymocytes in the various thymocyte subsets 
in Nur77-ZnCT transgenic mice expressed as a percentage of the 
number in a nontransgenic same-sex littermate control. Data is from 
line 15 and line 15 mice 3-5 weeks old. Each point represents the 
difference between a transgenic and nontransgenic control. Open cir- 
cles are data from Nur77-ZnCT heterozygous mice and triangles are 
data from homozygous mice. 
activation marker transiently up-regulated as the result of 
positive selection (Bendelac et al., 1992; Swat et al., 1993). 
In thymocytes from Nur77-ZnCT transgenic mice, CD89, 
HSA, and CD5 were found to be expressed in a normal 
pattern and at the same levels as in nontransgenic lit- 
termate controls. Thus, the dominant-negative Nur77 pro- 
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Figure 3. Antigen-Induced Deletion Is Inhibited in F5/Nur77-ZnCT 
Mice 
Flow cytometric analysis of CD4, CD6, and Vf311 staining of thymo- 
cytes from F5 TCR single-transgenic and F5 x ZnCT double- 
transgenic mice after injection of PBS or 50 nmol of nucleocapsid 
peptide daily for 4 days. Forward versus side light scatter of ungated 
thymocytes is shown. The total number of thymocytes after injection 
of PBS or peptide is indicated. In the experiment shown, mice were 
6-week-old male littermates. The experiment was repeated three times 
with similar results. In each experiment, same-sex littermates were 
used. 
tein does not block positive selection of thymocytes but 
does cause a change in the steady-state distribution of 
thymocytes among the various subsets of thymocytes. 
Antigen-Induced Negative Selection Is Inhibited 
by a Dominant-Negative Nur77 Protein 
After characterizing T cell maturation in Nur77-ZnCT 
transgenic mice, we crossed these mice with F5 TCR 
transgenic mice to examine an effect of the dominant- 
negative Nur77 protein on antigen-induced negative se- 
lection in vivo. F5 TCR transgenic mice provided condi- 
tions where negatively selected cells could be identified 
and, in theevent of a partial inhibition of negative selection, 
where the timing of deletion could be controlled. In F5 
mice, the majority of thymocytes express a transgenic F5 
TCR (Mamalaki et al., 1992, 1993). This receptor contains 
Vu4 and VP11 TCR segments and recognizes an influenza 
virus nucleocapsid peptide bound to Db class I molecules. 
In the absence of nucleocapsid peptide, F5 thymocytes 
undergo positive selection on Db, skewing development 
towards production of CD4-CD8+ cells. For the purposes 
of our analysis, negative selection of immature F5 thymo- 
cytes could be induced by injection of nucleocapsid pep- 
tide (Mamalaki et al., 1992, 1993). Thus, in the event of 
a partial inhibition of negative selection, the difference in 
the extent of deletion in F5 single-transgenic and F5/ 
Nur77-ZnCT double-transgenic mice could be compared. 
F5 single-transgenic and FS/Nur77-ZnCT double-trans 
genie mice were injected intraperitoneally with 50 nmol of 
NP peptide in phosphate-buffered saline (PBS) once a day 
for 4 days. Littermate controls were injected with PBS for 
the same period. On the fifth day, thymocytes from experi- 
mental and control mice were analyzed by flow cytometry 
for Vpl 1, CD4, and CD8 expression. In PBS-injected F5 
single-transgenic and F5/Nur77-ZnCT double-transgenic 
control mice, most thymocytes expressed V81 I and the 
majority of mature thymocytes were CD4-CD8+ cells (Fig- 
ure 3). In experimental F5 single-transgenic mice, injection 
of nucleocapsid peptide resulted in a severe reduction in 
total number of thymocytes. In addition, most thymocytes 
remaining in these mice were apoptotic, as measured by 
flow cytometry as a decrease in forward light scatter and 
an increase in side light scatter of the cells (Figure 3). 
There were very few CD4+CD8+ cells remaining after pep- 
tide injection, and of the total cells remaining only a small 
percentage expressed Vj311 (Figure 3). In contrast, the 
population of thymocytes remaining in F5/Nur77-ZnCT 
double-transgenic mice after injection of nucleocapsid 
peptide consisted primarily of viable cells, of which approx- 
imately 15% were CD4+CD8+ cells and 47.7% expressed 
Vpl 1 in the experiment shown (Figure 3). A difference in 
the extent of deletion clearly demonstrates an inhibition 
of antigen-induced negative selection by the dominant- 
negative Nur77 protein. A summary of experiments is 
shown in Table 1. 
Superantlgen-Induced Negative Selection Is Not 
Inhibited by a Dominant-Negatlve Nur77 Protein 
To examine the role of Nur77 in negative selection by 
superantigens, we crossed Nur77-ZnCT transgenic mice 
to CBA/J mice. The presence of the retroviral superanti- 
gens Mlslaand Mls2* in CBA/J mice as well as expression 
of MHC class II I-E molecules normally leads to deletion 
of T cells carrying V83, V88, and VP1 1, but not of T cells 
carrying V88.2N88.3 (Herman et al., 1991). In addition, 
Table 1. Inhibition of Negative Selection by a Dominant-Negative Nur77 Protein 
Experiments Transgenic Mice 
Number of viable cells 
after injection with 50 
nmol of NP peptide 
Percent of 
CD4+CDE+V611+ 
cells 
F5 2.8 x 106 <O.lO% 
F.5 x Nur77-ZnCT 4.8 x 10’ 15.8% 
F5 6.0 x 106 1.7% 
F5 x Nur77-ZnCT 1.7 x IO’ 36.6% 
F5 1.3 x 107 <0.3% 
F5 x Nur77-ZnCT 4.6 x 10’ 5.4% 
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the presence of Etc-1 retroviral antigens in C57BU6 mice 
leads to deletion of V65+ T cells in l-E+ mice (Woodland 
et al., 1990). We examined the percentages of V63+, 
V65+, VPS’, and V611’ CD4+CD6+ double-positive and 
CD4+CD6- single-positive thymocytes (Table 2) and V63+, 
V65+, V66+, and VP1 l+ CD4+ lymph node cells (Table 3) 
in wild-type and transgenic offspring from this cross. We 
did not detect any increase in the percentage of these 
cells in transgenic offspring, indicating that deletion by 
superantigens is not blocked by the dominant-negative 
Nur77 mutant. These results, together with the results of 
the F5 deletion experiment (above), suggest that either 
the molecular mechanisms of deletion by superantigens 
and antigens are different, or that the dominant-negative 
Nur77 mutant is only able to delay apoptosis in negatively 
selected thymocytes, as suggested by the F5 experiment. 
Thus, we may not be able to detect a partial inhibition of 
negative selection under steady-state conditions. 
Constitutive Nur77 Expression Results in a 
Reduction in Thymocyte Number 
We next examined Nur77-FL transgenic mice to deter- 
mine whether constitutive Nur77 expression induces 
apoptosis in developing thymocytes. Nur77-FL mice were 
found to have a 5- to 20.fold reduction in number of thymo- 
cytes, a reduction in number of lymph node cells, and 
normal numbers of splenocytes (Figure 4). Population of 
thymocytes from these mice were found to contain a large 
number of granular ceils, as measured by flow cytometry 
as an increase in side light scatter, suggesting an apop- 
totic morphology (Figure 5A). All 5 males examined be- 
tween 3-6 weeks old and 1 of the 5 females examined in 
this age group contained a population of granular thymo- 
cytes, although all Nur77-FL transgenic mice examined 
had a reduction in thymocyte number. A population of 
granular thymocytes has not been observed in older mice 
of either sex, suggesting that accumulation of these cells 
is age and sex dependent (see Discussion). 
Toverifythatgranularthymocytesin Nur77-FLtransgenic 
mice were apoptotic, TUNEL analysis (Gavrieli et al., 1992) 
was performed to identify cells with fragmented DNA. This 
analysis confirmed that granular thymocytes were in fact 
apoptotic (Figure 5B). Thus, constitutive Nur77 expression 
induces apoptosis in developing thymocytes, leading to 
a reduction in thymocyte number. 
To examine T cell development in Nur77-FL transgenic 
mice, thymocytes from these mice were examined by flow 
cytometry for expression of the coreceptor molecules CD4 
and CD6 and for CD3. In thymi containing a population 
of granular cells, there were very few immature CD4CD6’ 
and mature CD4+CD6-and CD4-CD6+ thymocytes (Figure 
5A). In thymi that did not contain the granular population, 
although there were fewer thymocytes, the relative per- 
centages of CD4+CD6+ and mature CD4+CD8- and 
CD4-CD8’ thymocytes were higher (Figure 5A). CD3 pro- 
files reflected the decrease in percentages of immature 
CD4+CD8+ and mature CD4+CD8- and CD4-CD8’ thymo- 
cytes (Figure 5A). These data demonstrate that the effect 
of constitutive Nur77 protein expression is more severe 
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Table 3. Percentage of Vf33, Vf35, Vf36, Vf311, and V68 CD4+ Lymph Node Cells in I-E- and I-E+ Non-Transgenic (Tg-) 
and Dominant-Negative Nur77 Transgenic (Tg’) Mice 
CD4’CD8- 
Ts I-E Percent Vp3+ Percent Vf35+ Percent V66’ Percent Vf3S+ Percent Vf31 I+ 
4.2 3.1 9.3 16.4 5.6 
-I- 3.7 3.7 9.0 15.7 4.7 
+ 0.27 (0.12) 0.53 (0.12) 1.10 (0.30) 16.70 (0.78) 0.37 (0.12) 
+ + 0.23 (0.06) 0.43 (0.23) 0.93 (0.35) 16.23 (0.15) 0.50 (0.17) 
Numbers represent the mean percentage of CD4+ lymph node T cells bearing each Vf3. For superantigen-positive I-E+ mice, data represent three 
independent animals. Standard deviations are shown in parentheses. 
in some mice than others. The severity of the phenotype 
correlates with an accumulation of granular apoptotic thy- 
mocytes in the thymus. 
To examine further T cell development in these mice, 
thymocytes were analyzed for the developmental marker 
CD69, CD5, and CD25 Expression of CD69 and CD5 was 
normal on thymocytes from Nur77-FL mice. However, low 
levels of CD25 the a chain of the interleukin-2 (IL-2) recep- 
tor, were detected on CD4+CD8+ thymocytes (data not 
shown). Expression of CD25 is normally down-regulated 
as thymocytes undergo expansion during the transition 
from the CDCCDB- stage to the CD4+CD8+ stage in devel- 
opment (Godfrey and Zlotnik, 1993). This observation 
raises the possibility of a problem during the CD4-CD8- 
to CD4+CD8+ transition (see Discussion). 
Lymph node cells and splenocytes from Nur77-FL mice 
were examined by flow cytometry for expression of CD4 
and CD8. Although transgenic mice 3-6 weeks old had 
populations of both CD4 and CD8 T cells (lymph node 
data is shown in Figure 6), the percentages of these cells 
were low compared with the percentages in nontransgenic 
littermate controls. Consistent with the reduction in the 
number of CD4 and CD8 T cells, the percentage of CD3+ 
cells was found to be low (Figure 6). Interestingly the num- 
ber of CD4 and CD8 T cells declined with age (Figure 6, 
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Figure 4. Total Number of Thymocytes, Lymph Node Ceils, and 
Splenocytes in Nur77 FL Transgenic Mice 3-6 weeks old 
The numbers in transgenic (Tg) and nontransgenic littermate controls 
(wt) are compared. 
lymph node data). The reduction in T cell number was 
observed in both the lymph nodes and spleen of Nur77- 
FL transgenic mice. These data demonstrate that Nur77- 
FL mice have fewer peripheral Tcells and that the number 
of these cells declines over time. 
Discussion 
We have investigated a role for the orphan steroid receptor 
Nur77 in the process of negative selection using a domi- 
nant-negative mutant of the Nur77 protein to inhibit endog- 
enous Nur77 function. Transgenic mice were generated in 
which thedominant-negative Nur77protein (Nur77-ZnCT) 
was expressed in developing thymocytes. These mice 
were then crossed with F5 TCR transgenic mice and nega- 
tive selection induced by injection of antigenic peptide. 
The extent of deletion of F5 thymocytes in F5 single- 
transgenic and F5/Nur77-ZnCT double-transgenic mice 
was compared. The dominant-negative protein was found 
to inhibit apoptosis significantly, providing in vivo evidence 
supporting a role for the Nur77 protein in antigen-induced 
negative selection. 
The role of Nur77 in the molecular mechanism of nega- 
tive selection by superantigens was examined by analyz- 
ing deletion in MMTV+ l-E+ dominant-negative Nur77 
transgenic mice. Expression of the dominant-negative 
Nur77 protein did not rescue Vf33+, Vj35+, Vf36+, or Vf31 l+ 
thymocytes from deletion by superantigens. Thus, the 
mechanisms of apoptosis in superantigen- and antigen- 
induced negative selection may be different. However, 
whereas the timing of deletion by peptide antigen was 
controlled, deletion by superantigens was examined un- 
der steady-state conditions. Thus, the possibility of a role 
for Nur77 in the process of superantigen deletion cannot 
be entirely ruled out for the following reasons. First, if the 
level of dominant-negative Nur77 protein is not sufficient 
to block endogenous Nur77 function entirely, apoptosis 
of negatively selected cells may only be delayed. Second, 
signals delivered during negative selection may result in 
commitment of a cell to the death pathway. Therefore, 
inhibiting the downstream events in negative selection 
may not necessarily result in maturation of negatively se- 
lected thymocytes but may instead only delay the death 
of these cells. 
To determine whether Nur77 expression alone could 
activate mechanisms leading to apoptosis of thymocytes, 
Nur77 protein was constitutively expressed in developing 
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thymocytes. Expression of Nur77 resulted in a significant 
reduction in numberofthymocytesandlymphnodeTcells. 
A population of thymocytes with a granular apoptotic mor- 
phology was observed by flow cytometry and confirmed 
as apoptotic using TUNEL. An accumulation of apoptotic 
thymocytes is somewhat surprising, since apoptotic cells 
are normally cleared very rapidly from the thymus by resi- 
dent macrophages (Savill et al., 1993; Surh and Sprent, 
1994; Veis et al., 1993). The presence of apoptotic cells 
in the thymus of some Nur77-FL mice suggests that either 
Figure 5. Severity of the Phenotype in the 
Nur77-FL Mice Correlates with the Presence 
of a Population of Granular Thymocytes 
(A) Representative FACS plots of 04, CD8, 
and CD3 expression on thymocytes from 
Nur77-FL transgenic mice comparing the se- 
verity of phenotypes. The thymus of some 
transgenic mice contain a large number of 
granular cells, as measured by an increase in 
forward and side light scatter. The presence of 
this population correlates with severity of the 
phenotype in the thymus. 
(B) TUNEL staining of thymocytes from a 
Nur77-FL transgenic mice confirms that gran- 
ular thymocytes are apoptotic 
the rate of apoptosis has exceeded the capacity of macro- 
phages to clear dead cells or that these cells have not yet 
been identified as apoptotic by macrophages. 
The effects of Nur77 expression appeared to be more 
pronounced in some mice than others. Our analysis to 
date indicates that the phenotype is more severe in young 
males. An increase in severity of the phenotype may result 
from additional effects of hormones during sexual matu- 
ration. 
Thymocytes in Nur77-FL mice appear to follow a normal 
sequence of developmental events with one exception. 
Low levels of CD25 are detected on CD4+CD8+ thymo- 
cytes. In normal mice, expression of CD25 is down- 
regulated before proliferation of thymocytes during a tran- 
sition from the CD4CD8- stage to the CD4+CD8+ stage 
in development. Low levels of CD25 have been observed 
on CD4+CD8+ thymocytes in <chain-deficient mice (Cromp 
ton et al., 1994). The possibility was raised that thymocytes 
in 5 chain-deficient mice had undergone fewer rounds of 
proliferation during the CD4-CD8- to CD4+CD8+ transition. 
CD25 expression was therefore not “diluted” from the sur- 
face of thymocytes through cell division during this transi- 
tion. The same possibility is raised here but probably re- 
sults from different reasons. Preliminary datasuggest that 
thymocytes in Nur77-FL transgenic mice are undergoing 
apoptosis during the CD4-CD8- to CD4+CD8+ proliferative 
transition. If Nur77 expression has an inhibitory effect on 
proliferation of thymocytes during this transition, it could 
explain both the expression of low levels of CD25 on dou- 
ble-positive thymocytes and apoptosis of some cells dur- 
ing this transition. Thus, apoptosis of thymocytes during 
the double-negative to double-positive transition is one 
possible explanation for the reduction in thymocyte num- 
bers in Nur77-FL transgenic mice. 
In addition, Nur77-FL transgenic mice have a decline 
in number of peripheral T cells. By 6 weeks of age, the 
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Figure 6. Representative FACS Plots of CD4, CD8, and CD3 Expres- 
sion on Lymph Node Cells from Nur77 Transgenic Mice 
Numbers of T cells decline with age. 
number of mature T cells remaining in these mice is very 
low. There are several possible explanations for this de- 
cline in T cell number. One is that T cells developing in 
these mice are less viable, and as the mice age the rate 
of T cell turnover in the periphery exceeds the rate of thy- 
mocyte maturation, resulting in a steady decline in T cell 
numbers. A second possibility is that, because of a prob- 
lem in thymocyte development, fewer T cells are maturing 
in Nur77-FL transgenic mice. These cells in the periphery 
are then attempting to increase in number and die because 
of an inhibitory effect of Nur77 on proliferation. 
We have examined our data in light of recent sugges- 
tions that Nur77 may regulate expression of Fas or the 
Fas ligand (Brunner et al., 1995; Dhein et al., 1995; Ju et 
al., 1995). Fas is a member of a family of receptors that 
includes the tumor necrosis factor (TNF) receptor (for re- 
view, see Crispe, 1994; Nagata and Golstein, 1995). Sig- 
nals delivered through Fas induce apoptosis in cells and 
an interaction between Fas and the Fas ligand has been 
shown to mediate TCR-signaled apoptosis of T cell hybrid- 
omas, leukemic T cells, and primary T cells growing in 
culture. Fas is constitutively expressed on immature 
CD4+CD8+ thymocytes and on mature CD4+CD8- and 
CD4-CD8+ thymocytes (for review, see Crispe, 1994; Na- 
gata and Golstein, 1995) whereas Fas ligand expression 
is inducible in thymocytes. One possible model for nega- 
tive selection involving Fas, the Fas ligand, and Nur77 
would argue that induction of Nur77 expression during 
negative selection leads to up-regulation of the Fas ligand 
and cell autonomous suicide in negatively selected cells. 
A variation on this model is that negatively selected cells 
become susceptible to Fas-mediated apoptosis and are 
killed by cells expressing the Fas ligand. However, experi- 
ments with /pr//pr mutant mice, which do not express Fas, 
suggests that Fas is not required for negative selection 
(Kotzin et al., 1988; Singer and Abbas, 1994; Singer et 
al., 1989; Zhou et al., 1991) and argue against a model 
for negative selection involving Fas. We have examined 
Fas levels on Nur77-FL transgenic thymocytes and 
Nur77-ZnCT transgenic thymocytes and have found no 
difference between the levels of Fas on these cells and 
on nontransgenic thymocytes. Experiments are in prog- 
ress to examine Fas ligand expression on negatively se- 
lected F5/Nur77-ZnCT double-transgenic thymocytes 
and on Nur77-FL transgenic thymocytes. 
We conclude by proposing a hypothesis for Nur77 func- 
tion in antigen-induced negative selection. Although 
downstream targets of Nur77 have yet to be identified in 
Tcells, we would like to propose that Nur77 may negatively 
regulate a process X required for proliferation and differen- 
tiation. During antigen-induced negative selection, a high 
affinity/avidity interaction between TCR and self-peptide/ 
MHC may result in an induction of a high level of Nur77 
protein. A strong inhibition by Nur77 of this process X in 
negatively selected thymocytes may result in apoptosis. 
Expression of the dominant-negative Nur77 protein in de- 
veloping thymocytes may have partially relieved an inhibi- 
tory effect of Nur77 on proliferation and differentiation. 
This effect was seen as a change in the steady-state distri- 
bution of thymocytes among the various subsets and an 
inhibition of negative selection. Constitutive expression of 
wild-type Nur77 may have increased the level of inhibition, 
CSUSing SpOptOSiS in thyI’fIOCyte8. 
Nur77 may have a similar function in neuronal cells in 
their response to proliferative and differentiative signals, 
as Nur77 expression has been correlated with both prolif- 
eration and differentiation in the neuronal cell line PC12. 
In addition, a role for Nur77 as a negative regulator has 
implications for the response of peripheral T cells to TCR 
signaling. Nur77 may be part of the downstream mecha- 
nisms in mature T cells that determine whether T cells 
respond to TCR signaling by proliferating, becoming aner- 
gic, or undergoing apoptosis. In HIV-infected individuals, 
Nur77may bepartof themechanismsthat lead toadecline 
in CD4+ T cells over time. Identifying downstream targets 
of Nur77 will further our understanding of the molecular 
mechanisms in positive and negative selection of thymo- 
cytes and the connections between proliferation, differen- 
tiation, and apoptosis. 
Experimental Procedures 
Construction of Transgenes 
An HgAI-EcoRV cDNA fragment encoding the Zn fingers through the 
C terminusof murine Nur77wasisolatedfrom theplasmidNlO(Ryseck 
et al., 1989) the ends of the fragment filled in with Klenow, and the 
fragment cloned into Smal in the vector pEVRF (Matthias, et al., 1989) 
by ligation of blunt ends. The cDNA was cloned in frame with a thymi- 
dine kinase (TK) ATG codon in pEVRF. TK-Nur77-ZnCT sequence 
was isolated from pEVRF by digestion with Sstl, the ends were filled 
in with Klenow, and the fragment cloned into the BamHl site in the 
plasmid ~1017 by ligation of blunt ends after filling in plasmid ends. 
TK-Nur77-ZnCT sequence was cloned upstream from the Ick proxi- 
mal promoter and regulatory sequences from the human growth hor- 
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mone gene contained in ~1017, generating the Nur77-ZnCT 
transgene. To construct the Nur77-FL transgene, the complete Nur77 
cDNA coding sequence was isolated from the plasmid NIO by diges- 
tion with EcoRl and cloned into the BamHl site in ~I017 by blunt-end 
ligation after filling in insert and plasmid ends. Nur77-&CT and 
Nur77-FLtransgenesequenceswere isolatedfrompl017bydigestion 
with Not1 and purified from plasmid sequence. 
Typing of Transgenlc Mice 
Purified transgene DNA was injected into (C57BL6 x CBA)FP embryos. 
Transgenic founders were identified by Southern blot analysis of tail 
DNA and transgenic lines established by outcrossing with C57BU6J 
mice. Fl offspring were typed by Southern blot analysis of tail DNA 
and later generations by polymerase chain reaction using the primers 
Ceder.2 (5’GCGGATC CGGGGAGGCATCTGGAGGCTG-3’) and N-ter 
(S-GGGGGATCTTGGTGG CGTG-3’) to type Nur77-&CT transgenic 
mice and Ceder-2 and NlO/E2 (5’.TTCCATGCCAGCAGCTTTCC-3’) 
to type Nur77-FL transgenic mice. Offspring of matings between het- 
erozygous Nur77-ZnCT transgenic mice were typed by Southern blot 
analysis of tail DNA. Transgene copy number was measured by phos- 
phorimaging analysis of endogenous and transgene bands to distin- 
guish heterozygous transgenic mice from homozygous transgenic 
mice. Ail mice were maintained in the pathogen-free Berkeley 
Transgenic Facility. 
Negative Selection in Nur’lt-ZnCT x F5 TCR Transgenic Mice 
The MHC haplotype of Nur77-ZnCT transgenic mice was determined 
by polymerase chain reaction using the following H-p and H-2r’ prim- 
ers: EK-5’ CATGGGCATAGAAAGGGCAGTCTFTGA ACT-J?, EA-5 
(5’-AGTCTTCCCAGCCTTCACACTCAGAGGTAC-3) and EA3’(5’- CA- 
TAGCCCCAAATGTCTGACCTCTGGAGAG-3’). F3 heterozygous Nuri7- 
ZnCT mice from line 16 (H-26) were crossed with homozygous F5 TCR 
transgenic mice (H-2b). An NP peptide (Ala-Ser-Asn-Glu-Asn-Met- 
Asp-Ala-Met [NP 366-3741) from the nucieocapsid peptide of the influ- 
enza virus AINT/60/66 was used to induce deletion. A control peptide 
(Ala-Ser-Asn-Glu-Asn-Met-Glu-Thr-Met [NP 366-3741) from the 
nucleocapsid of the influenza virus A/PR/6/34 did not induce deletion 
in either F5 single-transgenic or F5/Nur77-ZnCT double-transgenic 
mice. 
Ceil Count and Flow Cytometry 
Thymus, spleen, and lymph nodes were removed from mice and 
placed on ice in RPM medium containing 10% fetal calf serum. Cell 
suspensions were generated, filtered to remove tissue debris, and 
cells counted using a hemacytometer. After determining cell count, 
cells were washed twice with 1 x PBS supplemented with 2% fetal 
calf serum. Cells/sample (106) were stained on ice in 50 nl PBS, 2% 
fetal calf serum using the following antibodies: fluorescein isothiocya- 
nate (FITC)-conjugated antiCD6, phycoerythrin (PE)-conjugated anti- 
CD4 and anti-B220, biotinylated antiCD6, anti-CD3, anti-Vj33, V65. 
V66, andVj36.116.2 werepurchased from Caltag, and FITC-conjugated 
anti-HSA and biotinylated anti-V61 1, CD5, and CD25 were purchased 
from Pharmingen. Streptavidin-Tricolor (Caltag) was used as a second 
step reagent to detect biotinylated antibodies. Samples were analyzed 
on a Coulter EPICS XL flow cytometer. FACS plots were generated 
using WindMlDl developed by J. Trotter at the Salk Institute. 
Gel Mobility Shift Assays 
Whole cell extract for binding assays was generated as follows: single 
cell suspensions were made in RPM1 medium containing 10% fetal 
calf serum. Cells were filtered to remove tissue debris and washed 
once with 1 x PBS. Cells were resuspended in 50-l 00 pl of lysis buffer 
(Veis et al., 1993) depending on the number of cells, and incubated 
on ice for approximately IO min. Cellular debris was pelleted and ex- 
tract was removed to a fresh tube and stored at -60°C. To induce 
expression of endogenous Nur77, between 10’ and lOa thymocytes 
were plated in 10 ml of RPMI, 10% fetal calf serum and stimulated 
with 0.5 nm ionomycin and IO nglml PMAfor 2 hr at 37’C. Cells were 
washed once with 1 x PBS following stimulation before resuspension 
in lysis buffer. Protein concentration was determined by Bradford 
assay. Electrophoretic mobility shift assays were performed using a 
=P-labeled oligonucleotide probe containing a single Nur77 DNA bind- 
ing site (5”TCGAGTTTTAAAGGTCATGCTCAA TTTG-37 (Wilson et 
al., 1991). Whole cell extract(20 ng) was incubated with labeled probe 
in 25 nl of binding buffer (Davis et al., 1993) for 25 min at room tempera- 
ture. Complexes were resolved by polyacrylamide gel electrophoresis 
on a 4% acrylamide 0.5 x TBE gel. 
Western Blot Analysis 
Thymocyte whole cell extract was generated by the method of Veiss 
et. al. (1993) and 50 ug was run in each lane of a 12% polyacrylamide 
gel for SDS-poiyacrylamide gel electrophoresis. Protein was trans- 
ferred to nitrocellulose and stained with Ponceau lo verify that equal 
amounts of protein had been loaded in each lane. Extract from non- 
transgenic thymocytes, which had been stimulated with ionomycin and 
PMA to induce endogenous Nur77 expression, served as a positive 
control. Nitrocellulose was probed with 2El anti-mouse Nur77 mono- 
clonal antibody (a gift of Dr. J. Miibrandt). Blots were developed with 
enhanced chemiluminescence (DuPont NEN). 
TUNEL 
TdT labeling of thymocytes was performed according to the instruc- 
tions of the manufacturers, as follows: Thymocytes were fixed in 1% 
paraformaldehyde followed by permeabilization with 70% ethanol. 
Fragmented DNA ends were labeled with digoxigenin-1 l-dUTP using 
TdT and detected with a FITC-conjugated antidigoxigenin antibody. 
Samples were run on a Coulter EPICS XL flow cytometer. 
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